| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |